Top compounds associated with response to SEC16B


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.009
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.01
mRNA 5-FU CTRPv2 pan-cancer AAC 0.086 0.01
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA L-685458 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.082 0.01
mRNA Erlotinib gCSI pan-cancer AAC 0.14 0.01
mRNA ML320 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA YM-155 CTRPv2 pan-cancer AAC -0.089 0.02
Download CSV